LT-630
LT-630 is a HDAC6 inhibitor. LT-630 ameliorates liver injury by reducing oxidative damage[1].
Product Specifications
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lt-630.html
Solubility
10 mM in DMSO
Smiles
O=C(NO)C1=CC=C(CN2N=C(C(NC3=CC(F)=CC=C3)=O)C=C2C)C=C1
Molecular Formula
C19H17FN4O3
Molecular Weight
368.36
References & Citations
[1]Zhang GD, et al. A novel HDAC6 inhibitor attenuate APAP-induced liver injury by regulating MDH1-mediated oxidative stress. Int Immunopharmacol. 2024 Mar 13;131:111861.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC6
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
